Harsh Jain

1.7k total citations
59 papers, 518 citations indexed

About

Harsh Jain is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Modeling and Simulation. According to data from OpenAlex, Harsh Jain has authored 59 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 12 papers in Modeling and Simulation. Recurrent topics in Harsh Jain's work include Mathematical Biology Tumor Growth (12 papers), Prostate Cancer Treatment and Research (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Harsh Jain is often cited by papers focused on Mathematical Biology Tumor Growth (12 papers), Prostate Cancer Treatment and Research (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Harsh Jain collaborates with scholars based in United States, India and United Kingdom. Harsh Jain's co-authors include Trachette L. Jackson, Marisa C. Eisenberg, Jacques E. Nör, Michael Meyer‐Hermann, Avner Friedman, Steven K. Clinton, Avner Friedman, Helen M. Byrne, A. D. Hockley and Samuel K. Handelman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Harsh Jain

46 papers receiving 503 citations

Peers

Harsh Jain
Andrew Lin United States
Marit E. Hystad Norway
Guillaume Vogin France
Grigore Cernaianu Germany
W.-D. Beecken Germany
Paolo Tini Italy
Lunxu Liu China
Navid Redjal United States
Béla Bozóky Sweden
Ángel Pérez‐Núñez Spain
Andrew Lin United States
Harsh Jain
Citations per year, relative to Harsh Jain Harsh Jain (= 1×) peers Andrew Lin

Countries citing papers authored by Harsh Jain

Since Specialization
Citations

This map shows the geographic impact of Harsh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harsh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harsh Jain more than expected).

Fields of papers citing papers by Harsh Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harsh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harsh Jain. The network helps show where Harsh Jain may publish in the future.

Co-authorship network of co-authors of Harsh Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Harsh Jain. A scholar is included among the top collaborators of Harsh Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harsh Jain. Harsh Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Norton, Kerri‐Ann, et al.. (2025). Advances in surrogate modeling for biological agent-based simulations: trends, challenges, and future prospects. Journal of Mathematical Biology. 92(1). 6–6. 1 indexed citations
3.
Sankar, Jeyaraman, et al.. (2024). Obinutuzumab in Rheumatic Diseases: The New Kid on the Block!. Indian Journal of Rheumatology. 20(2). 179–181.
4.
Singh, Roop, et al.. (2023). How Not To Fix a Tibial Fracture: A Case Report on Treatment By a Quack. Cureus. 15(6). e40203–e40203. 2 indexed citations
5.
Singh, Roop, et al.. (2023). Report of a Rare Case of Pubic Symphysis Tuberculosis in an Eight-Year-Old Child: An Unusual Presentation of the Disease. Cureus. 15(3). e36149–e36149. 1 indexed citations
6.
Jain, Harsh, et al.. (2023). PATIENTS ON DIALYSIS RECEIVING ICD IMPLANTATION AT NO INCREASED RISK OF MORTALITY: A NATIONWIDE STUDY. CHEST Journal. 164(4). A324–A324. 1 indexed citations
7.
8.
Jain, Harsh, et al.. (2022). Combining Androgen Deprivation and Immunotherapy in Prostate Cancer Treatment: A Mechanistic Approach. Applied Sciences. 12(14). 6954–6954. 1 indexed citations
9.
10.
Handelman, Samuel K., et al.. (2020). Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition. Journal of The Royal Society Interface. 17(162). 20190722–20190722. 16 indexed citations
11.
Jain, Harsh, et al.. (2020). PRIMARY CARDIAC SARCOMA INVOLVING THE MITRAL VALVE: AN INSIDIOUS FORM OF HEART FAILURE. Journal of the American College of Cardiology. 75(11). 2937–2937. 2 indexed citations
12.
Jain, Harsh, et al.. (2020). Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC). Scientific Reports. 10(1). 10571–10571. 6 indexed citations
13.
Naqvi, Syed Yaseen, et al.. (2019). Management of Paravalvular Leak After Rapid Deployment Edwards Intuity Elite Valve. JACC: Cardiovascular Interventions. 12(5). e39–e40. 2 indexed citations
14.
Byrne, Helen M., et al.. (2019). A Biomechanical Model of Tumor-Induced Intracranial Pressure and Edema in Brain Tissue. Biophysical Journal. 116(8). 1560–1574. 20 indexed citations
15.
Friedman, Avner & Harsh Jain. (2013). A partial differential equation model of metastasized prostatic cancer. Mathematical Biosciences & Engineering. 10(3). 591–608. 6 indexed citations
16.
Jain, Harsh, Nicanor I. Moldovan, & Helen M. Byrne. (2012). Modeling Stem/Progenitor Cell-Induced Neovascularization and Oxygenation Around Solid Implants. Tissue Engineering Part C Methods. 18(7). 487–495. 3 indexed citations
17.
Jain, Harsh & Michael Meyer‐Hermann. (2010). The Molecular Basis of Synergism between Carboplatin and ABT-737 Therapy Targeting Ovarian Carcinomas. Cancer Research. 71(3). 705–715. 32 indexed citations
18.
Jain, Harsh, Jacques E. Nör, & Trachette L. Jackson. (2009). Quantification of endothelial cell–targeted anti–Bcl-2 therapy and its suppression of tumor growth and vascularization. Molecular Cancer Therapeutics. 8(10). 2926–2936. 16 indexed citations
19.
Hirose, Hitoshi, et al.. (2007). Comparison of eight prosthetic aortic valves in a cadaver model. Journal of Thoracic and Cardiovascular Surgery. 134(6). 1526–1532. 3 indexed citations
20.
Dong, Zhihong, Benjamin D. Zeitlin, Qinghua Sun, et al.. (2007). Level of endothelial cell apoptosis required for a significant decrease in microvessel density. Experimental Cell Research. 313(16). 3645–3657. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Lin Breakdown of academic impact, for papers by Marit E. Hystad Breakdown of academic impact, for papers by Guillaume Vogin Breakdown of academic impact, for papers by Grigore Cernaianu Breakdown of academic impact, for papers by W.-D. Beecken Breakdown of academic impact, for papers by Paolo Tini Breakdown of academic impact, for papers by Lunxu Liu Breakdown of academic impact, for papers by Navid Redjal Breakdown of academic impact, for papers by Béla Bozóky Breakdown of academic impact, for papers by Ángel Pérez‐Núñez
Rankless by CCL
2026